ATE401906T1 - Sedative stoffe und behandlungen - Google Patents

Sedative stoffe und behandlungen

Info

Publication number
ATE401906T1
ATE401906T1 AT03701586T AT03701586T ATE401906T1 AT E401906 T1 ATE401906 T1 AT E401906T1 AT 03701586 T AT03701586 T AT 03701586T AT 03701586 T AT03701586 T AT 03701586T AT E401906 T1 ATE401906 T1 AT E401906T1
Authority
AT
Austria
Prior art keywords
treatments
sedative
substances
methylapigenin
linarin
Prior art date
Application number
AT03701586T
Other languages
English (en)
Inventor
Nora Marder
Jorge Medina
Alejandro Paladini
Haydee Viola
Cristina Wasowski
Original Assignee
Univ Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0201669A external-priority patent/GB0201669D0/en
Priority claimed from GB0217792A external-priority patent/GB0217792D0/en
Application filed by Univ Strathclyde filed Critical Univ Strathclyde
Application granted granted Critical
Publication of ATE401906T1 publication Critical patent/ATE401906T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/84—Valerianaceae (Valerian family), e.g. valerian
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT03701586T 2002-01-25 2003-01-24 Sedative stoffe und behandlungen ATE401906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0201669A GB0201669D0 (en) 2002-01-25 2002-01-25 Sedative materials and treatments
GB0217792A GB0217792D0 (en) 2002-08-01 2002-08-01 Sedative materials and treatments - II

Publications (1)

Publication Number Publication Date
ATE401906T1 true ATE401906T1 (de) 2008-08-15

Family

ID=27614799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03701586T ATE401906T1 (de) 2002-01-25 2003-01-24 Sedative stoffe und behandlungen

Country Status (4)

Country Link
EP (1) EP1503771B1 (de)
AT (1) ATE401906T1 (de)
DE (1) DE60322376D1 (de)
WO (1) WO2003061678A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1721613B1 (de) * 2005-05-13 2007-11-28 Mewicon med. wiss. Beratung GmbH Hesperidin zur Behandlung von Epilepsie
CN102477054A (zh) * 2010-11-25 2012-05-30 苏州宝泽堂医药科技有限公司 一种制备刺槐苷的方法
WO2013186220A1 (en) 2012-06-11 2013-12-19 Bioactor B.V. Compositions comprising hesperidin and/or apigenin i.a. for medical use or for use in treatment of sleeping disorders
WO2013185301A1 (zh) * 2012-06-13 2013-12-19 Jin Yongri 黄酮及二氢黄酮衍生物在制备镇静、催眠药物中的用途
WO2014048968A1 (en) * 2012-09-28 2014-04-03 Unilever Plc Frozen confection comprising valerenic acid and one or more flavones
KR102139253B1 (ko) * 2018-05-04 2020-07-29 (주)노아스 시트러스 과피 추출물을 포함하는 카페인에 의한 수면장애 개선용 조성물
JP6826347B2 (ja) * 2018-05-23 2021-02-03 長崎県公立大学法人 冷え性改善用、肩こり改善用、疲労回復用又は睡眠改善用の組成物、それを含む食品、薬剤、組成物キット、及び、その組成物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1191515B (de) * 1963-01-26 1965-04-22 Kali Chemie Ag Verfahren zur Gewinnung von sedativ und spasmolytisch wirksamen Estern aus Radix valerianae
DE3112737A1 (de) * 1981-03-31 1982-10-07 Gehrlicher Kg Verfahren zur gewinnung epoxidfreier sedierender wirkstoffe aus pflanzen der familie valerianaceae
CA2379395A1 (en) * 1999-07-21 2001-02-01 Ancile Pharmaceuticals, Inc. Process for the extraction of valerian root

Also Published As

Publication number Publication date
EP1503771A1 (de) 2005-02-09
EP1503771B1 (de) 2008-07-23
DE60322376D1 (de) 2008-09-04
WO2003061678A1 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
DE69924607D1 (de) Benzimidazol-derivate als ige-modulatoren
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
ATE464303T1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
ATE450530T1 (de) Zusammensetzungen zur verwendung als protein- kinase-inhibitoren
IS8349A (is) 2,4-pýrimídíndíamín gagnleg í meðhöndlun æxlissjúkdóma, bólgu- og ónæmiskerfissjúkdóma
HRP20050826B1 (hr) Ciklički inhibitori proteinske tirozin kinaze
DE60314500D1 (de) Diaminopyrimidine und deren verwendung als angiogenesehemmer
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EP1670307A4 (de) Koordinierte verringerung und verstärkung der genexpression von mehr als einem gen mit hilfe von transgenen konstrukten
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
ATE482213T1 (de) Als inhibitoren von proteinkinasen geeignete pyrazoloä1,5-aüpyrimidine
DE60325761D1 (de) Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
DK1754707T3 (da) Multicykliske forbindelser og anvendelse deraf som inhibitorer af PARP-, VEGFR2- og MLK3-enzymer
DE602004021037D1 (de) Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
ATE389649T1 (de) Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen
ITMI20050262A1 (it) Sostanze composizioni e metodi di trattamento dell'alopecia
MEP20908A (en) Thienopyrazoles
NO20061291L (no) Ny formulering
EP1572118A4 (de) Verfahren und zusammensetzungen zur behandlung von krebs mit 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216
ATE336996T1 (de) Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem
DE60117606D1 (de) Orale zusammensetzungen zur behandlung von kopfhauterkrankungen
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
ATE434614T1 (de) 4,6-disubstitutierte pyrimidine und deren verwendung als proteinkinase-hemmer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties